DIA Stock Overview
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostic and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China.
Price History & Performance
|Historical stock prices|
|Current Share Price||€142.85|
|52 Week High||€208.80|
|52 Week Low||€133.30|
|1 Month Change||-11.74%|
|3 Month Change||-24.38%|
|1 Year Change||-18.37%|
|3 Year Change||77.67%|
|5 Year Change||157.16%|
|Change since IPO||1,053.88%|
Recent News & Updates
Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DiaSorin S.p.A...
Is DiaSorin (BIT:DIA) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Is DiaSorin (BIT:DIA) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|DIA||IT Medical Equipment||IT Market|
Return vs Industry: DIA underperformed the Italian Medical Equipment industry which returned 7.4% over the past year.
Return vs Market: DIA underperformed the Italian Market which returned 21.4% over the past year.
|DIA Average Weekly Movement||5.7%|
|Medical Equipment Industry Average Movement||6.4%|
|Market Average Movement||4.3%|
|10% most volatile stocks in IT Market||7.1%|
|10% least volatile stocks in IT Market||2.7%|
Stable Share Price: DIA is more volatile than 75% of Italian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: DIA's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostic and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. It provides various immunodiagnostic platforms, including LIAISON, LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform, comprising of LIAISON MDX. DiaSorin S.p.A. has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of Point-of-Care molecular platform; and MeMed for the launch of a test differentiating between viral and bacterial infections.
DiaSorin Fundamentals Summary
|DIA fundamental statistics|
Is DIA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DIA income statement (TTM)|
|Cost of Revenue||€367.00m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||5.75|
|Net Profit Margin||27.84%|
How did DIA perform over the long term?See historical performance and comparison
0.7%Current Dividend Yield
Is DiaSorin undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: DIA (€142.85) is trading above our estimate of fair value (€111.61)
Significantly Below Fair Value: DIA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: DIA is good value based on its PE Ratio (24.8x) compared to the European Medical Equipment industry average (32.5x).
PE vs Market: DIA is poor value based on its PE Ratio (24.8x) compared to the Italian market (19.4x).
Price to Earnings Growth Ratio
PEG Ratio: DIA is poor value based on its PEG Ratio (13.9x)
Price to Book Ratio
PB vs Industry: DIA is overvalued based on its PB Ratio (6.3x) compared to the XE Medical Equipment industry average (4.4x).
How is DiaSorin forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DIA's forecast earnings growth (1.8% per year) is above the savings rate (1.8%).
Earnings vs Market: DIA's earnings (1.8% per year) are forecast to grow slower than the Italian market (11% per year).
High Growth Earnings: DIA's earnings are forecast to grow, but not significantly.
Revenue vs Market: DIA's revenue (5% per year) is forecast to grow faster than the Italian market (-0.1% per year).
High Growth Revenue: DIA's revenue (5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DIA's Return on Equity is forecast to be low in 3 years time (19.5%).
How has DiaSorin performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DIA has high quality earnings.
Growing Profit Margin: DIA's current net profit margins (27.8%) are higher than last year (26.7%).
Past Earnings Growth Analysis
Earnings Trend: DIA's earnings have grown significantly by 20.1% per year over the past 5 years.
Accelerating Growth: DIA's earnings growth over the past year (48.8%) exceeds its 5-year average (20.1% per year).
Earnings vs Industry: DIA earnings growth over the past year (48.8%) underperformed the Medical Equipment industry 62.2%.
Return on Equity
High ROE: DIA's Return on Equity (25.4%) is considered high.
How is DiaSorin's financial position?
Financial Position Analysis
Short Term Liabilities: DIA's short term assets (€-702.0M) do not cover its short term liabilities (€154.6M).
Long Term Liabilities: DIA's short term assets (€-702.0M) do not cover its long term liabilities (€108.8M).
Debt to Equity History and Analysis
Debt Level: DIA's net debt to equity ratio (93.2%) is considered high.
Reducing Debt: DIA's debt to equity ratio has reduced from 10.2% to 8.8% over the past 5 years.
Debt Coverage: DIA's debt is well covered by operating cash flow (373.5%).
Interest Coverage: DIA's interest payments on its debt are well covered by EBIT (34.5x coverage).
What is DiaSorin current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: DIA's dividend (0.7%) isn’t notable compared to the bottom 25% of dividend payers in the Italian market (1.03%).
High Dividend: DIA's dividend (0.7%) is low compared to the top 25% of dividend payers in the Italian market (3.44%).
Stability and Growth of Payments
Stable Dividend: DIA's dividends per share have been stable in the past 10 years.
Growing Dividend: DIA's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (17.4%), DIA's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: DIA's dividends in 3 years are forecast to be well covered by earnings (23.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Carlo Rosa (55 yo)
Mr. Carlo Rosa has been the Chief Executive Officer of DiaSorin S.p.A. since 2006 and has been its General Manager since April 27, 2010 also its Executive Director since March 26, 2007. In 2001, Mr. Rosa l...
CEO Compensation Analysis
Compensation vs Market: Carlo's total compensation ($USD2.22M) is about average for companies of similar size in the Italian market ($USD1.84M).
Compensation vs Earnings: Carlo's compensation has been consistent with company performance over the past year.
Experienced Management: DIA's management team is considered experienced (4.4 years average tenure).
Experienced Board: DIA's board of directors are seasoned and experienced ( 11.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
DiaSorin S.p.A.'s employee growth, exchange listings and data sources
- Name: DiaSorin S.p.A.
- Ticker: DIA
- Exchange: BIT
- Founded: 1968
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €7.817b
- Shares outstanding: 54.72m
- Website: https://www.diasoringroup.com
Number of Employees
- DiaSorin S.p.A.
- Via Crescentino snc
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/21 21:16|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.